Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H26N2O4 |
| Molecular Weight | 382.4528 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO\C=C(/[C@H]1C[C@@H]2N(CC[C@@]23C(=O)NC4=CC=CC=C34)C[C@@H]1C=C)C(=O)OC
InChI
InChIKey=MUVGVMUWMAGNSY-VKCGGMIFSA-N
InChI=1S/C22H26N2O4/c1-4-14-12-24-10-9-22(17-7-5-6-8-18(17)23-21(22)26)19(24)11-15(14)16(13-27-2)20(25)28-3/h4-8,13-15,19H,1,9-12H2,2-3H3,(H,23,26)/b16-13+/t14-,15-,19-,22-/m0/s1
| Molecular Formula | C22H26N2O4 |
| Molecular Weight | 382.4528 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Isocorynoxeine is one of four bioactive tetracyclic oxinole alkaloids which can be isolated from Uncaria hooks used in traditional Chinese and Kampo medicines. The traditional remedies are claimed to have sedative and anti-spasmodic effects, however, isocorynoxeine does not appear to cross the blood-brain barrier. It is suspected that one or more metabolites of isocorynoxeine produce the effect of lower blood pressure, vasodilation and protection against ischemic neural damage. Furthermore, isocoynoxine has also shown reduce the viability of multi-drug resistant cancer cells when used in conjunction with doxycycline
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21442303
Curator's Comment: referenced study was conducted in rat
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0046209 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18588343 |
13.7 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Secondary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Uncaria alkaloids reverse ABCB1-mediated cancer multidrug resistance. | 2017-07 |
|
| Isolation and identification of twelve metabolites of isocorynoxeine in rat urine and their neuroprotective activities in HT22 cell assay. | 2015-01 |
|
| Metabolites of isocorynoxeine in rats after its oral administration. | 2015 |
|
| Alkaloids from the leaves of Uncaria rhynchophylla and their inhibitory activity on NO production in lipopolysaccharide-activated microglia. | 2008-07 |
|
| [Anti-convulsion effects of choto-san and chotoko (Uncariae Uncis cam Ramlus) in mice, and identification of the active principles]. | 1997-12 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25633191
An oral dose of 40 mg/kg of isocorynoxeine was fed to rats. After dosing bile was drained and analyzed by LC-MS in order to identify metabolites of isocorynoxeine.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25519834
Isocorynooxeine and several metabolites were tested for the ability to protect against 3 mM glutamate-induced cell death in immortalized an HT22-cell line. HT22 cells were cultured in DMEM supplemented with 10% FBS at 37 deg-C in a 5% CO2 and 95% air atmosphere. Cells were incubated 24 hours before being treated with 1 - 100 micro-M of each test sample and 3 mM glutamate. Isocorynoxeine exhibited significant neuroprotective effects against glutamate-induced cell death at the maximum concentration of 100 micro-M. However little neuroprotection was observed for the tested metabolites.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:49:57 GMT 2025
by
admin
on
Mon Mar 31 22:49:57 GMT 2025
|
| Record UNII |
J18B596D11
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3037448
Created by
admin on Mon Mar 31 22:49:57 GMT 2025 , Edited by admin on Mon Mar 31 22:49:57 GMT 2025
|
PRIMARY | |||
|
DTXSID701317164
Created by
admin on Mon Mar 31 22:49:57 GMT 2025 , Edited by admin on Mon Mar 31 22:49:57 GMT 2025
|
PRIMARY | |||
|
J18B596D11
Created by
admin on Mon Mar 31 22:49:57 GMT 2025 , Edited by admin on Mon Mar 31 22:49:57 GMT 2025
|
PRIMARY | |||
|
51014-29-0
Created by
admin on Mon Mar 31 22:49:57 GMT 2025 , Edited by admin on Mon Mar 31 22:49:57 GMT 2025
|
PRIMARY | |||
|
2562547
Created by
admin on Mon Mar 31 22:49:57 GMT 2025 , Edited by admin on Mon Mar 31 22:49:57 GMT 2025
|
PRIMARY | |||
|
J18B596D11
Created by
admin on Mon Mar 31 22:49:57 GMT 2025 , Edited by admin on Mon Mar 31 22:49:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |